The Team
A world leading microbiome team on a mission
We are a multidisciplinary team of research scientists and drug development experts who are at the forefront of microbiome research, looking to discover and develop microbiome-based therapies.
The translation of research into the development of innovative and life-saving microbiome-based therapies are further bolstered by BiomeBank’s partnership with world-leading biomedical research organisations. This includes RMIT University, Hudson Institute of Medical Research, and Hospital Networks globally.
The Management Team
Sam Costello
Managing Director // CEO // Co-founder
Aurelie Muhl
Head of Quality
Sam Forster
Chief Technology Officer
Emily Tucker
Head of Donor Screening
Rob Bryant
VP Translational Medicine // Co-founder
Mirjana Rapaic
Head of Regulatory Affairs
Chelsea Bickley
Head of Production
Lisa Dann
Head of Microbiology